前列腺癌范式的演变:前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描在原发分期和治疗决策中的核心作用
本文为叙述性综述,聚焦PSMA PET/CT在局限性原发前列腺癌中的前瞻性证据。目前最常见实践是用于高危前列腺癌的原发淋巴结和转移分期,并描述了其在中危前列腺癌、局部分期及影响放疗和手术管理中的作用,以及诊断前风险分层、预后和特定手术角色等未来潜力,同时讨论了潜在陷阱。
要点
- PSMA PET/CT目前最常见实践是用于高危前列腺癌的原发淋巴结和转移分期。
- 综述描述了PSMA PET/CT在中危前列腺癌、局部分期及影响放疗和手术管理中的作用。
- 综述讨论了PSMA PET/CT在诊断前风险分层、预后和特定手术角色等未来潜力及潜在陷阱。
核心结论
- PSMA PET/CT已对前列腺癌产生显著影响,其在局限性原发前列腺癌中的作用将继续扩大。
研究设计与样本
- 叙述性综述,聚焦PSMA PET/CT在局限性原发前列腺癌中的前瞻性证据。
主要发现
- 大多数早期证据和前瞻性试验评估了PSMA PET/CT在生化复发或转移 setting 中的应用,但原发 setting 的前瞻性试验数量在增加。
- 目前PSMA PET/CT最常见的实践是用于高危前列腺癌的原发淋巴结和转移分期。
- 综述描述了PSMA PET/CT在中危前列腺癌、局部分期及对放疗和手术管理影响中的作用。
- 综述讨论了PSMA PET/CT在诊断前如活检风险分层、预后和特定手术角色等方面的潜在未来作用,并涉及潜在陷阱。
临床怎么用
- 目前PSMA PET/CT最常见的实践是用于高危前列腺癌的原发淋巴结和转移分期。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Prostate-specific membrane antigen (PSMA) positron emission tomography or computed tomography (PET/CT) has emerged as a superior imaging option to conventional imaging for prostate cancer. The majority of early evidence and prospective trials evaluated PSMA PET/CT in the biochemical recurrence or metastatic setting. However, there has been an increasing number of prospective trials in the primary setting. The purpose of this narrative review was to describe the role of PSMA PET/CT in localized primary prostate cancer. This narrative review focuses on the prospective evidence available in this setting. We detail the current practice and future potential for PSMA PET/CT to be used in multiple stages of localized primary prostate cancer. The most common practice currently for PSMA PET/CT is in the primary nodal and metastatic staging of high-risk prostate cancer. We describe other roles of PSMA PET/CT, including in intermediate-risk prostate cancer as well as local staging and the impact on radiation therapy and surgical management. We also discuss the potential future roles of PSMA PET/CT in prediagnosis such as risk stratification for biopsy, prognosis, and specific surgical roles. Potential pitfalls of PSMA PET/CT are also addressed. PSMA PET/CT has already had a significant influence on prostate cancer, and there will continue to be a greater role for this imaging modality in localized primary prostate cancer.
引用
- Udovicich C, Jia AY, Loblaw A, et al. Evolving Paradigms in Prostate Cancer: The Integral Role of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Primary Staging and Therapeutic Decision-Making. Int J Radiat Oncol Biol Phys. 2024. PMID: 39278417. doi:10.1016/j.ijrobp.2024.08.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。